Soliton (SOLY) Stock Price, News & Analysis

Company Overview

Soliton, Inc. is a medical development company, which engages in the development of healthcare technological devices for medical and cosmetic treatments. Its technology platform include Rapid Acoustic Pulse, a device uses rapid pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. The firm is also in the pre-revenue stage with its first products being developed for the removal of tattoos and the reduction of cellulite. The company was founded by Walter V. Klemp and Christopher Capelli on March 27, 2012 and is headquartered in Houston, TX.

Key Stats

• Today's Range: $22.58 to $22.58
• 50-Day Range: $20.10 to $22.58
• 52-Week Range: $7.40 to $22.60
• Volume: N/A
• Average Volume: 347,827 shs
• Market Capitalization: $487.66 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SOLY Stock Analysis - Frequently Asked Questions

How were Soliton's earnings last quarter?

Soliton, Inc. (NASDAQ:SOLY) released its earnings results on Thursday, August, 12th. The company reported ($0.37) EPS for the quarter, missing analysts' consensus estimates of ($0.30) by $0.07.

What other stocks do shareholders of Soliton own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Soliton investors own include BMO Capital Markets (), Stifel Nicolaus (), Wunderlich (), Standpoint Research (), Duncan Williams (), Soleil Securities () and Sterne Agee CRT ().

Company Calendar

• Last Earnings: 8/12/2021
• Today: 7/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & Medical Instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:SOLY
• CIK: 1548187
• Web: www.soliton.com
• Phone: (844) 705-4866
• Fax: N/A
• Employees: 14
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($1.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$14.54 million
• Net Margins: N/A
• Pretax Margin: -4,831.89%
• Return on Equity: -71.85%
• Return on Assets: -62.92%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.47
• Quick Ratio: 5.37

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.46 per share
• Price / Book: 15.47

Miscellaneous

• Outstanding Shares: 21,597,000
• Free Float: 19,005,000
• Market Cap: $487.66 million
• Optionable: Not Optionable
• Beta: 0.19